InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.012

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Appendix 3B-Receipt of Funds & Issue of Shares to Fujifilm 25 Jan 2017 6:18PM $0.645 $0.012 fallen by 98.14%
$3 Appendix 4C - quarterly 25 Jan 2017 4:33PM $0.645 $0.012 fallen by 98.14%
$3 Cynata Successfully Completes Capital Raising 23 Jan 2017 10:03AM $0.780 $0.012 fallen by 98.46%
$3 Trading Halt 19 Jan 2017 9:14AM $0.780 $0.012 fallen by 98.46%
$3 Cynata & FUJIFILM Sign Strategic Partnership Agreement 19 Jan 2017 8:25AM $0.780 $0.012 fallen by 98.46%
$3 Proposed Fujifilm Development&Commercialisation Transaction 29 Dec 2016 4:20PM $0.715 $0.012 fallen by 98.32%
$3 Cynata's Clinical Study Approved in Austrralia 15 Dec 2016 11:49AM $0.670 $0.012 fallen by 98.21%
$3 Cynata Receives NHS HRA Approval for Clinical Study 13 Dec 2016 10:30AM $0.600 $0.012 fallen by 98%
$3 Change of Share Registry Address 9 Dec 2016 2:13PM $0.630 $0.012 fallen by 98.10%
$3 Cynata Files Further Patent Application 29 Nov 2016 9:58AM $0.710 $0.012 fallen by 98.31%
$3 Appendix 3Y x 4 17 Nov 2016 6:18PM $0.780 $0.012 fallen by 98.46%
$3 Appendix 3B 17 Nov 2016 6:17PM $0.780 $0.012 fallen by 98.46%
$3 Results of AGM 16 Nov 2016 9:58AM $0.680 $0.012 fallen by 98.24%
$3 AGM Presentation 16 Nov 2016 8:59AM $0.680 $0.012 fallen by 98.24%
$3 Cynata Receives $1.749m R&D Tax Incentive Refund 15 Nov 2016 3:41PM $0.690 $0.012 fallen by 98.26%
$3 Activities Report & Appendix 4C 31 Oct 2016 5:29PM $0.670 $0.012 fallen by 98.21%
$3 Efficacy for CYP MSC Technology in Preclinical Asthma Study 17 Oct 2016 9:37AM $0.550 $0.012 fallen by 97.82%
$3 Annual Report to Shareholders 13 Oct 2016 5:56PM $0.560 $0.012 fallen by 97.86%
$3 Notice of Annual General Meeting/Proxy Form 13 Oct 2016 5:53PM $0.560 $0.012 fallen by 97.86%
$3 Trading Halt 19 Sep 2016 11:10AM $0.515 $0.012 fallen by 97.67%
$3 UK Regulatory Authority Approves Cynata GvHD Clinical Trial 19 Sep 2016 12:54AM $0.515 $0.012 fallen by 97.67%
$3 Expiry of Unlisted Options 12 Sep 2016 8:53AM $0.410 $0.012 fallen by 97.07%
$3 Appendix 3Y-Stewart Washer 9 Sep 2016 12:58AM $0.420 $0.012 fallen by 97.14%
$3 Corporate Presentation 7 Sep 2016 8:39AM $0.430 $0.012 fallen by 97.21%
$3 CYP Determines not to proceed with Regience Investment Offer 5 Sep 2016 10:14AM $0.370 $0.012 fallen by 96.76%

601 - 625 of 699 results

Page 25 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.